V7M-13407-64158
3 vaccinations
10 coded responses
31 check-ins
10 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 837 / ID
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
DMJ-32853-11624
Child or adolescent in my care · Female · 2021-12-10
LC5-27273-86344
Child or adolescent in my care · Male · 2021-12-10
FDT-17841-82571
Child or adolescent in my care · Female · 2022-01-01
Timeline
-
2020-12-27
Dose 1 — Moderna
-
2021-01-07
Registered in v-safe
- 2021-01-07
- 2021-01-10
- 2021-01-17
- 2021-01-24
-
2021-01-26
Dose 2 — Moderna
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
-
2021-01-28
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessFree text: Large supraclavicular lymph node on same side as vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-29
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Swollen lymph nodes on left supraclavicular areaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-01
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-04-27
- 2021-07-27
-
2021-12-09
Dose 3 — Pfizer-BioNTech
-
2021-12-10
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness, NauseaFree text: Swollen supraclavicular lymph nodeMedDRA releases: 2024-11 · check-in free text available
-
2021-12-11
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain, Hyperhidrosis, Lymphadenopathy, Night sweats, Oedema peripheral — Feeling: Fair · Site: PainFree text: Drenching night sweat, persistent supraclavicular lymphadenopathy and sore axillary swellingMedDRA releases: 2024-11 · check-in free text available
-
2021-12-12
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Headache, Fatigue or tirednessFree text: Painful swollen lymph nodesMedDRA releases: 2024-11 · check-in free text available
-
2021-12-13
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: GoodFree text: Painful swollen supraclavicular lymph nodeMedDRA releases: 2024-11 · check-in free text available
- 2021-12-15
- 2021-12-16
- 2021-12-24
-
2021-12-30
Survey response — day 21, dose 3MedDRA: Upper respiratory tract infection — Feeling: GoodFree text: Mild URIMedDRA releases: 2024-11 · check-in free text available
-
2022-01-07
Survey response — day 28, dose 3MedDRA: Nasal congestion, Rhinorrhoea, Viral upper respiratory tract infection — Feeling: GoodFree text: Viral URI. Nasal congestion and runny nose x 5 days.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-13
- 2022-01-20
- 2022-03-10
-
2022-06-09
Survey response — 6 months, dose 3MedDRA: COVID-19, Laryngitis, Viral upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Viral URI currently with laryngitis. Had COVID in AprilMedDRA releases: 2024-11 · check-in free text available
- 2022-12-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-27 | Moderna | |
| 2 | 2021-01-26 | Moderna | |
| 3 | 2021-12-09 | Pfizer-BioNTech | No |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Large supraclavicular lymph node on same side as vaccine
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph nodes on left supraclavicular area
Systemic reaction (other): Swollen lymph nodes
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen supraclavicular lymph node
Systemic reaction (other): Drenching night sweat, persistent supraclavicular lymphadenopathy and sore axillary swelling
Systemic reaction (other): Painful swollen lymph nodes
Systemic reaction (other): Painful swollen supraclavicular lymph node
Release 10 — day 21, dose 3
Symptoms: Mild URI
Release 10 — day 28, dose 3
Symptoms: Viral URI. Nasal congestion and runny nose x 5 days.
Release 12 — 6 months, dose 3
Symptoms: Viral URI currently with laryngitis. Had COVID in April
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Laryngitis | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SD | Viral upper respiratory tract infection | · | · | ✓ |
| SRO | Axillary pain | · | · | ✓ |
| SRO | Hyperhidrosis | · | · | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Night sweats | · | · | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release